Chukkalore, D., Aung, W. Y., Cheranda, N., Puttagunta, N., Guevara, N., Seetharamu, N. (2026). Impact of first-line
                    <i>EGFR</i>
                    TKI dose reduction on survival and treatment sequencing in metastatic
                    <i>EGFR</i>
                    -mutant non–small cell lung cancer: A real-world cohort study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e20746